Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Biological age & clocks
Video summary

Dog Aging Project scientist describes epigenetic clocks and faster aging in larger dog breeds

In this video description, a Dog Aging Project scientist presents DNA methylation clocks for dogs, steeper epigenetic aging slopes in larger breeds, and dysregulated transposable elements, while noting limits of consumer tests. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The description introduces Blaise Mariner as a postdoctoral scientist at Arizona State University working on the Dog Aging Project with Noah Snyder-Mackler. [1]

  2. The description says larger dog breeds show faster epigenetic aging slopes and that transposable elements are dysregulated faster in bigger dogs. [1]

  3. The description lists a segment on consumer epigenetic age tests for dogs, framed as promise and limitations. [1]

The source at a glance

Study type / format
Video description of a research interview episode
Population / context
Dogs in the Dog Aging Project, as described, across breeds and body sizes.
Summary based on
Creator description
Original publication
July 28, 2026

Described guest and epigenetic clock topics

The description introduces Blaise Mariner, a postdoctoral scientist at Arizona State University working with Noah Snyder-Mackler on the Dog Aging Project. It says he specializes in epigenetics, DNA methylation and computational biology, and how these influence aging rates across dog breeds. The listed topics include how chemical modifications to DNA can reveal a dog's biological age, separate from chronological age, and a comparison of chronological versus biological age. These are topics the episode says it explores; the description does not report results of that comparison.

Supporting source [1]

Larger breeds and transposable elements in the description

The description says larger dog breeds show faster epigenetic aging slopes and links this to lifespan differences. It also lists transposable elements, described as mobile DNA elements, and says they are dysregulated faster in bigger dogs. A further listed topic is methylation drift, described as older dogs losing control of mobile DNA elements. The description presents these as topics covered in the episode, not as quantified findings; it gives no effect sizes, sample numbers or follow-up.

Supporting source [1]

Mendelian randomization and consumer test caveats

The description lists Mendelian randomization as a statistical approach for identifying causal links between methylation patterns and outcomes such as mobility, and includes a segment on what "causal" really means in epigenetics research. It also lists a segment on consumer epigenetic age tests for dogs, framed as promise and limitations, and says owners should know about these tests and their limitations. The description does not state which tests, what they measure or any accuracy figures. It also mentions non-invasive biomarkers and longitudinal tracking as opportunities ahead.

Supporting source [1]

How to interpret this

This is only the video description; the video and transcript were not reviewed. Topics are listed without reported results, sample sizes or effect sizes. The cited works are bioRxiv preprints and a mouse-focused study; the description does not establish human or clinical benefits.

Based on the creator’s description; the full video and transcript were not analyzed.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    postdoctoral scientist at Arizona State University working
  2. Finding 2 ↑

    larger dog breeds show faster epigenetic aging
  3. Finding 3 ↑

    Consumer epigenetic age tests for dogs

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…